CVE-2019-25721Dräger Infinity M300 VG2.3.1 Network-Based Denial of Service
Updated under an hour ago ()
Does this affect you?
It affects Dräger Infinity M300. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 0.19%, higher than 8% of scored CVEs.
Do this next
Free account, 1 product
Dräger Infinity M300 patient worn monitors with software version VG2.3.1 and earlier contain a network-based denial of service vulnerability that allows network-adjacent attackers to repeatedly trigger device reboots by sending malicious requests over the Infinity Network. Attackers can exploit this vulnerability to force the device into a fail state requiring manual restart, causing loss of wireless connectivity and interruption of patient monitoring functionality.
- CVSS
- 6.5 MEDIUM (v3.1, CNA)CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
- Weakness (CWE)
- CWE-400
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 0.19% (percentile 8)
- Assigned by
- VulnCheck
- NVD analysis
- Awaiting Analysis
- Record last updated
- Jun 3, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
Dräger Infinity M300 drager:infinity_m300 (from the name) | through VG2.3.1; VG2.3.2 not affected | CNA record |
References
- https://static.draeger.com/security/download/2019-09-13-Cybersecurity-M300-VGxx-Security-advisory-update_v1-3.pdfvendor-advisory
- https://www.vulncheck.com/advisories/dr-ger-infinity-m300-vg2-network-based-denial-of-servicethird-party-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.